intestinal barriers

临床试验

计划入组 50 人 · 首次发布于 2024 年 3 月 20 日

尚未招募

NCT07796035

Understanding Communication Barriers in Acute Care: A Mixed-Methods Needs Assessment Among Healthcare Providers Caring for Non-Verbal Patients With Spinal Cord Injury and Tracheostomy in the ICU

计划入组 100 人 · 首次发布于 2026 年 8 月 31 日

撤回

NCT06596538

Video-Interpreting in an Emergency Trauma Room Setting - a Feasibility Trial

计划入组 50 人 · 首次发布于 2024 年 9 月 19 日

药物

查看全部 38 →

Small Molecule

Investigational

Vasoactive intestinal peptide

C₁₄₇H₂₃₇N₄₃O₄₃S

Intestinal trefoil factor

Oral alkaline phosphatase (Synthetic Biologics)

机构

查看全部 8 →

AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP

Australia

GEDII - GRUPO DE ESTUDO DA DOENÇA INFLAMATÓRIA INTESTINAL

Portugal

Oncolytics Biotech Inc

Canada

资讯

查看全部 2210 →

去年

Experimental Celiac Drug Shows Promise in Treating Children with Post-COVID Inflammatory Syndrome

去年

Novel Mango-Flavored Pill Shows Promise in Eradicating Intestinal Worms

9个月前

临床试验

Video-Interpreting in Prehospital Emergency Medicine - Feasibility Study

Understanding Communication Barriers in Acute Care: A Mixed-Methods Needs Assessment Among Healthcare Providers Caring for Non-Verbal Patients With Spinal Cord Injury and Tracheostomy in the ICU

Video-Interpreting in an Emergency Trauma Room Setting - a Feasibility Trial

药物

Vasoactive intestinal peptide

Intestinal trefoil factor

Oral alkaline phosphatase (Synthetic Biologics)

机构

AUSTRALASIAN GASTRO-INTESTINAL TRIALS GROUP

GEDII - GRUPO DE ESTUDO DA DOENÇA INFLAMATÓRIA INTESTINAL

Oncolytics Biotech Inc

资讯

Experimental Celiac Drug Shows Promise in Treating Children with Post-COVID Inflammatory Syndrome

Novel Mango-Flavored Pill Shows Promise in Eradicating Intestinal Worms

Gut-Brain Axis Emerges as Key Pathway in Parkinson's Disease Pathogenesis